Santen Pharmaceutical Dividends and Buybacks
Dividend criteria checks 3/6
Santen Pharmaceutical is a dividend paying company with a current yield of 2.59%.
Key information
2.6%
Dividend yield
5.6%
Buyback Yield
| Total Shareholder Yield | 8.2% |
| Future Dividend Yield | 2.9% |
| Dividend Growth | -0.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | -83% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4536 N's dividends per share have been stable in the past 10 years.
Growing Dividend: 4536 N's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Santen Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4536 N) | 2.6% |
| Market Bottom 25% (MX) | 2.6% |
| Market Top 25% (MX) | 7.0% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (4536 N) (up to 3 years) | 2.9% |
Notable Dividend: 4536 N's dividend (2.59%) is higher than the bottom 25% of dividend payers in the MX market (2.31%).
High Dividend: 4536 N's dividend (2.59%) is low compared to the top 25% of dividend payers in the MX market (7.29%).
Earnings Payout to Shareholders
Earnings Coverage: 4536 N is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (95.1%), 4536 N's dividend payments are not well covered by cash flows.